Crispr Therapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.0M | 16k | 64.81 |
| 2025-06-30 | $1.4M | 29k | 48.64 |
| 2025-03-31 | $969k | 29k | 34.03 |
| 2024-12-31 | $1.1M | 29k | 39.36 |
| 2024-09-30 | $1.3M | 29k | 46.98 |
| 2024-06-30 | $1.5M | 29k | 54.01 |
| 2024-03-31 | $1.9M | 29k | 68.16 |
| 2023-09-30 | $1.4M | 30k | 45.39 |
| 2023-06-30 | $1.7M | 30k | 56.14 |
| 2023-03-31 | $1.3M | 28k | 45.23 |
| 2022-06-30 | $2.3M | 37k | 60.78 |